Company Data
Design Therapeutics Inc.
Ticker
DSGN
Current Price
$10.37 3.7%
Market Cap
$590.7M
Price Target
Refer to Report
Volume
189.7K
52wk Range
$2.6 - $11.14
Overview
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.